12:00 AM
Feb 02, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BC-819: Phase I/II start

In 1H09, BioCancell will begin an international Phase I/IIa trial to evaluate intraperitoneal BC-819 in 12 patients.


Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >